Cannara Biotech to enter the U.S. hemp-CBD market with launch of online e-commerce platform

Twitter icon

Montreal-headquartered Cannara Biotech Inc. plans to enter the U.S. hemp-CBD market, through a subsidiary, with an online e-commerce platform called

“The new e-commerce platform will showcase retail products from hemp-CBD manufacturers for the U.S. consumer market,” states a press release from Cannara Biotech, a vertically integrated cannabis company focused on cannabis-infused products.

The idea is that the e-commerce platform—which is said to have attracted commitment from several vendors so far—will “offer a variety of products, including tinctures, oils, capsules, body care, vape cartridges and pet-related products,” the statement notes. The company reports consumers will be able to purchase, review and compare a variety of CBD products.

“We are taking a leadership role by creating a hub for vendors to showcase their products and consumers to purchase hemp-CBD products in a fast and easy way. We want to become the Amazon of CBD,” says Zohar Krivorot, president and CEO of Cannara Biotech.

“With the recent passing of the 2018 Farm Bill in the U.S., CBD represents an emerging sector with many vendors seeking national reach to U.S. customers,” notes the company, whose strategy is “to offer a wide variety of products from leading CBD brands, with competitive pricing and delivery times across the U.S.”

Citing figures from industry analysts at Brightfield Group, Cannara Biotech reports that “the hemp-derived CBD market is expected to reach US$22 billion by 2022.”

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Regional Marijuana News: